New pill aims to let patients step into the sun without pain
Symptom relief
Ongoing
This study is testing whether an investigational drug called MT-7117 can help people with rare light-sensitive skin disorders (EPP or XLP) spend more time in sunlight before feeling painful burning or itching. About 165 participants, aged 12 to 75, will take either the drug or a …
Phase: PHASE3 • Sponsor: Tanabe Pharma America, Inc. • Aim: Symptom relief
Last updated Mar 30, 2026 14:33 UTC